TONIX PHARMACEUTICALS HOLDING CORP. Investing Cash Flow
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Investing Cash Flow of -$2.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$587.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$1.69M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.02M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$962.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities for fiscal 2025 was -$4.53M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities for fiscal 2024 was -$120.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities for fiscal 2023 was -$29.07M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities for fiscal 2022 was -$48.15M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 55 month | Net Cash Provided by (Used in) Investing Activities 58 month | Net Cash Provided by (Used in) Investing Activities 61 month | Net Cash Provided by (Used in) Investing Activities 64 month | Net Cash Provided by (Used in) Investing Activities 67 month | Net Cash Provided by (Used in) Investing Activities 70 month | Net Cash Provided by (Used in) Investing Activities 73 month | Net Cash Provided by (Used in) Investing Activities 76 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$587.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$2.28M 10-Q · filed 2026-08-10 | -$3.30M derived: sum of 3 quarters · filed 2026-08-10 | -$4.26M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||
| 2026-03-31 | -$1.69M 10-Q · filed 2026-05-11 | -$2.71M derived: sum of 2 quarters · filed 2026-05-11 | -$3.67M derived: sum of 3 quarters · filed 2026-05-11 | -$6.21M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||
| 2025-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.98M derived: sum of 2 quarters · filed 2026-03-12 | -$4.52M derived: sum of 3 quarters · filed 2026-08-10 | -$4.53M 10-K · filed 2026-03-12 | ||||||||
| 2025-09-30 | -$962.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.50M derived: sum of 2 quarters · filed 2026-08-10 | -$3.51M 10-Q · filed 2025-11-10 | -$3.51M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||
| 2025-06-30 | -$2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$2.54M 10-Q · filed 2026-08-10 | -$2.55M derived: sum of 3 quarters · filed 2026-08-10 | -$2.56M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||
| 2025-03-31 | -$6.00K 10-Q · filed 2026-05-11 | -$9.00K derived: sum of 2 quarters · filed 2026-05-11 | -$18.00K derived: sum of 3 quarters · filed 2026-05-11 | -$18.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||||||
| 2024-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$12.00K derived: sum of 2 quarters · filed 2026-03-12 | -$12.00K derived: sum of 3 quarters · filed 2026-03-12 | -$120.00K 10-K · filed 2026-03-12 | ||||||||
| 2024-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$9.00K derived: sum of 2 quarters · filed 2025-11-10 | -$117.00K 10-Q · filed 2025-11-10 | -$548.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$108.00K 10-Q · filed 2025-08-11 | -$539.00K derived: sum of 3 quarters · filed 2025-08-11 | -$1.36M derived: sum of 4 quarters · filed 2025-08-11 | ||||||||
| 2024-03-31 | -$108.00K 10-Q · filed 2025-05-12 | -$539.00K derived: sum of 2 quarters · filed 2025-05-12 | -$1.36M derived: sum of 3 quarters · filed 2025-05-12 | -$25.38M derived: sum of 4 quarters · filed 2025-05-12 | ||||||||
| 2023-12-31 | -$431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$1.25M derived: sum of 2 quarters · filed 2025-03-18 | -$25.27M derived: sum of 3 quarters · filed 2025-03-18 | -$29.07M 10-K · filed 2025-03-18 | ||||||||
| 2023-09-30 | -$821.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$24.84M derived: sum of 2 quarters · filed 2024-11-12 | -$28.64M 10-Q · filed 2024-11-12 | -$33.31M derived: sum of 4 quarters · filed 2024-11-12 | ||||||||
| 2023-06-30 | -$24.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | -$27.82M 10-Q · filed 2024-08-16 | -$32.49M derived: sum of 3 quarters · filed 2024-08-16 | -$41.31M derived: sum of 4 quarters · filed 2024-08-16 | ||||||||
| 2023-03-31 | -$3.80M 10-Q · filed 2024-05-13 | -$8.47M derived: sum of 2 quarters · filed 2024-05-13 | -$17.29M derived: sum of 3 quarters · filed 2024-05-13 | -$31.73M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2022-12-31 | -$4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$13.49M derived: sum of 2 quarters · filed 2024-04-01 | -$27.93M derived: sum of 3 quarters · filed 2024-04-01 | -$48.15M 10-K · filed 2024-04-01 | ||||||||
| 2022-09-30 | -$8.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$23.26M derived: sum of 2 quarters · filed 2023-11-09 | -$43.48M 10-Q · filed 2023-11-09 | -$69.10M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||
| 2022-06-30 | -$14.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$34.66M 10-Q · filed 2023-08-10 | -$60.28M derived: sum of 3 quarters · filed 2023-08-10 | -$68.03M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | -$20.22M 10-Q · filed 2023-05-08 | -$45.84M derived: sum of 2 quarters · filed 2023-05-08 | -$53.59M derived: sum of 3 quarters · filed 2023-05-08 | -$55.02M derived: sum of 4 quarters · filed 2023-05-08 | ||||||||
| 2021-12-31 | -$25.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$33.37M derived: sum of 2 quarters · filed 2023-03-13 | -$34.80M derived: sum of 3 quarters · filed 2023-03-13 | -$35.31M 10-K · filed 2023-03-13 | ||||||||
| 2021-09-30 | -$7.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$9.18M derived: sum of 2 quarters · filed 2022-11-07 | -$9.69M 10-Q · filed 2022-11-07 | -$14.22M derived: sum of 4 quarters · filed 2022-11-07 | ||||||||
| 2021-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$1.93M 10-Q · filed 2022-08-08 | -$6.47M derived: sum of 3 quarters · filed 2022-08-08 | -$10.48M derived: sum of 4 quarters · filed 2022-08-08 | ||||||||
| 2021-03-31 | -$505.00K 10-Q · filed 2022-05-09 | -$5.04M derived: sum of 2 quarters · filed 2022-05-09 | -$9.05M derived: sum of 3 quarters · filed 2022-05-09 | |||||||||
| 2020-12-31 | -$4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$8.55M derived: sum of 2 quarters · filed 2022-03-14 | -$8.56M 10-K · filed 2022-03-14 | |||||||||
| 2020-09-30 | -$4.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$4.03M 10-Q · filed 2021-11-08 | ||||||||||
| 2020-06-30 | -$14.00K 10-Q · filed 2021-08-09 | |||||||||||
| 2019-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$7.00K derived: sum of 2 quarters · filed 2021-03-15 | -$10.00K derived: sum of 3 quarters · filed 2021-03-15 | -$17.00K 10-K · filed 2021-03-15 | ||||||||
| 2019-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$5.00K derived: sum of 2 quarters · filed 2020-11-09 | -$12.00K 10-Q · filed 2020-11-09 | -$11.00K derived: sum of 4 quarters · filed 2020-11-09 | ||||||||
| 2019-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$10.00K 10-Q · filed 2020-08-10 | -$9.00K derived: sum of 3 quarters · filed 2020-08-10 | -$12.00K derived: sum of 4 quarters · filed 2020-08-10 | ||||||||
| 2019-03-31 | -$7.00K 10-Q · filed 2020-05-12 | -$6.00K derived: sum of 2 quarters · filed 2020-05-12 | -$9.00K derived: sum of 3 quarters · filed 2020-05-12 | -$11.00K derived: sum of 4 quarters · filed 2020-05-12 | ||||||||
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | -$2.00K derived: sum of 2 quarters · filed 2020-03-24 | -$4.00K derived: sum of 3 quarters · filed 2020-03-24 | -$6.00K 10-K · filed 2020-03-24 | ||||||||
| 2018-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$5.00K derived: sum of 2 quarters · filed 2019-11-08 | -$7.00K 10-Q · filed 2019-11-08 | -$10.00K derived: sum of 4 quarters · filed 2019-11-08 | ||||||||
| 2018-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$4.00K 10-Q · filed 2019-08-12 | -$7.00K derived: sum of 3 quarters · filed 2019-08-12 | -$7.00K derived: sum of 4 quarters · filed 2019-08-12 | ||||||||
| 2018-03-31 | -$2.00K 10-Q · filed 2019-05-13 | -$5.00K derived: sum of 2 quarters · filed 2019-05-13 | -$5.00K derived: sum of 3 quarters · filed 2019-05-13 | $2.47M derived: sum of 4 quarters · filed 2019-05-13 | ||||||||
| 2017-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$3.00K derived: sum of 2 quarters · filed 2019-03-18 | $2.48M derived: sum of 3 quarters · filed 2019-03-18 | $7.17M 10-K · filed 2019-03-18 | ||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $2.48M derived: sum of 2 quarters · filed 2018-11-09 | $7.17M 10-Q · filed 2018-11-09 | $11.03M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2017-06-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $7.17M 10-Q · filed 2018-08-13 | $11.03M derived: sum of 3 quarters · filed 2018-08-13 | |||||||||
| 2017-03-31 | $4.69M 10-Q · filed 2018-05-11 | $8.55M derived: sum of 2 quarters · filed 2018-05-11 | ||||||||||
| 2016-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $16.55M 10-K · filed 2018-03-09 | ||||||||||
| 2016-09-30 | $12.69M 10-Q · filed 2017-11-06 | |||||||||||
| 2013-09-30 | -$8.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$8.19K derived: sum of 2 quarters · filed 2013-11-13 | -$8.21K 10-Q · filed 2013-11-13 | -$8.23K derived: sum of 4 quarters · filed 2013-11-22 | -$147.01K 10-Q · filed 2013-11-13 | |||||||
| 2013-06-30 | -$23.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$45.00 10-Q · filed 2013-08-14 | -$68.00 derived: sum of 3 quarters · filed 2013-11-22 | -$1.95K derived: sum of 4 quarters · filed 2013-11-22 | -$138.85K 10-Q · filed 2013-08-14 | |||||||
| 2013-03-31 | -$22.00 10-Q · filed 2013-05-07 | -$45.00 derived: sum of 2 quarters · filed 2013-11-22 | -$1.93K derived: sum of 3 quarters · filed 2013-11-22 | -$35.76K derived: sum of 4 quarters · filed 2013-11-22 | -$138.82K 10-Q · filed 2013-05-07 | |||||||
| 2012-12-31 | -$23.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | -$1.90K derived: sum of 2 quarters · filed 2013-11-22 | -$35.74K derived: sum of 3 quarters · filed 2013-11-22 | -$35.76K 10-K/A · filed 2013-11-22 | -$138.80K 10-K/A · filed 2013-11-22 | |||||||
| 2012-09-30 | -$1.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$35.72K derived: sum of 2 quarters · filed 2013-11-13 | -$35.74K 10-Q · filed 2013-11-13 | -$35.78K derived: sum of 4 quarters · filed 2013-11-22 | -$138.78K 10-Q · filed 2012-11-14 | |||||||
| 2012-06-30 | -$33.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$33.86K 10-Q · filed 2013-08-14 | -$33.90K derived: sum of 3 quarters · filed 2013-11-22 | -$33.90K derived: sum of 4 quarters · filed 2013-11-22 | -$136.90K 10-Q · filed 2012-08-13 | |||||||
| 2012-03-31 | -$22.00 10-Q · filed 2013-05-07 | -$67.00 derived: sum of 2 quarters · filed 2013-11-22 | -$67.00 derived: sum of 3 quarters · filed 2013-11-22 | -$14.68K derived: sum of 4 quarters · filed 2013-11-22 | -$103.06K 10-Q · filed 2012-05-15 | |||||||
| 2011-12-31 | -$45.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | -$45.00 derived: sum of 2 quarters · filed 2013-11-22 | -$14.65K derived: sum of 3 quarters · filed 2013-11-22 | $302.00 10-K/A · filed 2013-11-22 | -$103.04K 10-K · filed 2012-03-30 | |||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$14.61K derived: sum of 2 quarters · filed 2012-11-14 | $347.00 10-Q · filed 2012-11-14 | |||||||||
| 2011-06-30 | -$14.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $347.00 10-Q · filed 2012-08-13 | ||||||||||
| 2011-03-31 | $14.96K 10-Q · filed 2012-05-15 | |||||||||||
| 2010-12-31 | -$94.37K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |